STAT

Tom Marsilje, a relentless advocate for cancer patients, dies at 45

Tom Marsilje was eternally optimistic and willing to give of his time to help his fellow cancer patients find clinical trials and experimental therapies.

When Tom Marsilje launched a website in May to help people with late-stage colorectal cancer find possible treatments through clinical trials, he pointed out the irony: “The ultimate CRC clinical trial advocate is unlikely to ever do a clinical trial,” he said.

He was right.

Marsilje, a Novartis scientist who helped develop a cutting-edge lung cancer treatment — and who, after his own colon cancer diagnosis, became a fierce advocate for his fellow patients — died Tuesday afternoon at a hospital in San Diego. He was 45.

The cancer support community was reeling in the wake of the

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: IVF Doctors Demand Full Details On Fluid That Grows Embryos Amid CooperSurgical Lawsuits
Patients from all over the country are filing lawsuits against medical supply giant CooperSurgical, alleging that fluid the company sent to in vitro fertilization clinics destroyed their embryos. The fluid, called culture media, is filled with nutrie
STAT1 min read
Disparities In Donor Acceptance Rates Point To Need For More Equitable Heart Transplant Care
While access to donor hearts has increased, there are still gender- and race-based disparities in the acceptance rate of a donor heart offer by transplant teams, a new study finds.
STAT1 min read
STAT+: AstraZeneca Sues Arkansas Over The Role Of Pharmacies In A Federal Discount Drug Program
AstraZeneca filed a lawsuit seeking to block an Arkansas law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a federal discount program.

Related Books & Audiobooks